𝔖 Bobbio Scriptorium
✦   LIBER   ✦

On future non-medical costs in economic evaluations

✍ Scribed by Bengt Liljas; Göran S. Karlsson; Nils-Olov Stålhammar

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
142 KB
Volume
17
Category
Article
ISSN
1057-9230

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Economic evaluation in health care is still an evolving discipline. One of the current controversies in cost‐effectiveness analysis regards the inclusion or exclusion of future non‐medical costs (i.e. consumption net of production) due to increased survival. This paper examines the implications of a symmetry rule stating that there should be consistency between costs included in the numerator and utility aspects included in the denominator. While the observation that no quality‐adjusted life year (QALY) instruments explicitly include consumption and leisure seems to give support to the notion that future non‐medical costs should be excluded when QALYs are used as the outcome measure, a better understanding of what respondents actually consider when reporting QALY weights is required. However, the more fundamental question is whether QALYs can be interpreted as utilities. Or more precisely, what are the assumptions needed for a general utility model also including consumption and leisure to be consistent with QALYs? Once those assumptions are identified, they need to be experimentally tested to see whether they are at least approximately valid. Until we have answers to these areas for future research, it seems premature to include future non‐medical costs. Copyright © 2007 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Illustrating the impact of including fut
Illustrating the impact of including future costs in economic evaluations: an application to end-stage renal disease care
✍ Braden Manns; David Meltzer; Ken Taub; Cam Donaldson 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract There are strong theoretical arguments for including future costs for related and unrelated medical care and non‐medical expenditures within economic evaluations. Nevertheless, there is limited data on how inclusion of such costs affects the cost effectiveness of medical interventions i

Indirect cost in economic evaluation: Th
Indirect cost in economic evaluation: The opportunity cost of unpaid inputs
✍ John Posnett; Stephen Jan 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 941 KB

Unpaid time represents a potentially significant input into the health production function. The paper sets out the basis for valuation of time inputs consistent with the notion of opportunity cost. Such analysis requires consideration of whether time displaced in the production of health involves lo

Correcting for compensating mechanisms r
Correcting for compensating mechanisms related to productivity costs in economic evaluations of health care programmes
✍ Karin H. M. Jacob-Tacken; Marc A. Koopmanschap; Willem Jan Meerding; Johan L. Se 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

## Abstract In the economic evaluation of health care programmes, productivity costs are often estimated using patients' wages for the period of absence. However, the use of such methods for short periods of absence is controversial. A previous study found that short‐term absence is often compensat

Biases in cost measurement for economic
Biases in cost measurement for economic evaluation studies in health care
✍ Philip Jacobs; Jean-François Baladi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB 👁 2 views

This paper addresses the issue of biases in cost measures which are used in economic evaluation studies. The basic measure of hospital costs which is used by most investigators is unit cost. Focusing on this measure, a set of criteria which the basic measures must fulfil in order to approximate the

Estimating production costs in the econo
Estimating production costs in the economic evaluation of health-care programs
✍ Carmen Herrero; Juan D. Moreno-Ternero 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB 👁 3 views

## Abstract We propose a method for calculating the production costs of an intervention in a manner that accounts for differences in productive ‘effort.’ This method could be used within a cost‐effectiveness analysis framework in the evaluation of new medical technologies, pharmaceuticals, treatmen